PerkinElmer Picks Up Nexcelom for $260 Million to Expedite Drugs to Market | BioSpace
PerkinElmer's Oxford Immunotec Receives U.S. FDA Approval for T-Cell Select To Automate Clinically Superior Tuberculosis Detection | Technology Networks
FlexDrop iQ Non-contact Dispenser | PerkinElmer
We're excited to announce that PerkinElmer has reached an agreement to acquire Oxford Immunotec, headquartered near Oxford, UK. This… | Instagram
Perkinelmer to acquire Oxford Immunotec for $591M | 2021-01-07 | BioWorld
TGA 8000 | PerkinElmer
NexION 5000 Multi-Quadrupole ICP Mass Spectrometer | PerkinElmer
PerkinElmer to Acquire Oxford Immunotec Global | Clinical Lab Products
OilExpress 4 DUO | In-Service Oil Condition Monitoring | PerkinElmer
PerkinElmer's Oxford Immunotec Receives U.S. FDA Approval for T-Cell Select to Automate Clinically Superior Tuberculosis Detection - Oxford Immunotec North America
Convenzis - Our Clients
Oxford Immunotec North America | Oxford Immunotec is a leading global diagnostics company with an 18-year history of transforming T cell science into meaningful insights.
PerkinElmer's Oxford Immunotec Receives U.S. FDA Approval for T-Cell Select - The Indian Practitioner
Opera Phenix Plus High-Content Screening System | PerkinElmer
PerkinElmer to acquire diagnostics company Oxford Immunotec for $591m
IVIS® Spectrum In Vivo Imaging System | PerkinElmer
LQA 300 FT-IR Wine Analyzer | PerkinElmer
GC Instruments | PerkinElmer
Oxford Immunotec Presents Data on the Use of T-SPOT.TB Test in Children over the Age of 2 toThe Korean Society of Pediatric Infectious Diseases | T-SPOT.TB: Latent TB test